Neimeth International Pharmaceuticals Plc has appointed Pharm. Matthew Obi Azoji as its new Managing Director (MD)/Chief Executive Officer (CEO). The company disclosed this in a notice sent to the Nigerian Stock Exchange (NSE) today.

Pharm Azoji will resume his appointment as the company’s MD/CEO on Friday, February 1, 2019.

Pharm. Matthew Obi Azoji’s profile

Pharm. Azoji graduated from the Obafemi Awolowo University, Ile-Ife, Osun State, where he obtained his B. Pharm (First Class Honours). He went on to obtain an MBA (Marketing) from the Enugu State University of Science and Technology, Enugu, and an Advanced Management Programme (AMP) from the Lagos Business School; Pan Atlantic University, Lagos.

He obtained certificates in Pharmaceutical Policy & Pharmacoeconomics from Utrecht University in the Netherlands (a WHO Collaborating centre), and went on to get his M.Sc. in Public health from the University of London, International Programmes. He obtained his M.Phil (Pharmacy Administration) from Obafemi Awolowo University, lle-Ife. Presently, a PhD (Clinical Pharmacy & Pharmacy Practice) from the University of Jos, Jos Plateau State is in view.

Pharm. Azoji is Fellow, Pharmaceutical Society of Nigeria (FPSN) and Fellow, West African Postgraduate College of Pharmacists (FPCPHARM). He is a Member, International Pharmaceutical Federation (FIP), Founding Member, Health Systems Action Network (HSAN), Member, Nigerian Institute of Management (MNIM), Member, National Institute of Marketing of Nigeria and Member, Nigerian Association of Industrial Pharmacists.

He began his professional career as a Hospital Pharmacist at General Hospital Saminaka, Kaduna State in 1986 serving our country during his National Youth Service Corps (NYSC) year. Prior to this, he had a one year internship programme at Obafemi Awolowo University, lle-Ife as a Demonstrator/Internee. He had a brief stint with Astra-Arewa Pharmaceuticals Ltd, Kaduna as a Medical Representative based in Kano. He joined May & Baker Nigeria Plc in 1988, and served there till 2004, during which time he rose from the position of Medical Representative to occupy the positions of Asst. Manager – Ethical Product Sales, Area Manager – North, Sales & Market Development Manager, Regional Sales Manager – Lagos/South West, Business Manager – Healthcare, Business Manager – Consumer and Head, Corporate Planning & Development. He was the pioneer MD/CEO, CHAN Medi-Pharm Ltd/Gte, Jos, Plateau State from 2004 till Sept. 2018.

Pharm. Azoji served on the boards and management of Ecumenical Pharmaceutical Network (EPN) and Africa Christian Health Associations Platform (ACHAP) both based in Nairobi, Kenya.

About Neimeth

Neimeth International Pharmaceuticals Plc was incorporated on 30th August 1957 as a limited liability company. It commenced operations in 1958. On May 14th, 1997, Pfizer NY divested from the company through a management buyout. The company then underwent a name change to Neimeth Plc.

FCMB ads 300 x 250

Neimeth is currently trading at N0.70 in today’s session on the Nigerian Stock Exchange (NSE).

Deal book 300 x 250

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.